Återgå till huvudnavigering
Återgå till sök
Gå direkt till huvudinnehållet
Lunds universitet Hem
English
Svenska
Sök innehåll hos Lunds universitet
Hem
Profiler
Forskningsoutput
Projekt
Enheter
Infrastruktur
Aktiviteter
Priser och utmärkelser
Dataset
Olof Grip
Knuten till universitetet
Docent
,
Internmedicin - epidemiologi
Telefon
+4640336156
E-postadress
olof.grip
med.lu
se
Översikt
Fingeravtryck
Nätverk
Forskningsoutput
(74)
Projekt
(1)
Liknande profiler
(6)
Handlett arbete
(1)
Fingeravtryck
Utforska forskningsämnen där Olof Grip är aktiv. Dessa ämnesetiketter kommer från personens arbeten. Tillsammans bildar de ett unikt fingeravtryck.
Sortera efter
Vikt
Alfabetisk ordning
Medicine and Dentistry
Patient
100%
Therapeutic Procedure
48%
Inflammatory Bowel Disease
36%
Cohort Analysis
27%
Patient with Inflammatory Bowel Disease
26%
Spontaneous Remission
21%
Patient with Crohn's Disease
17%
Hazard Ratio
15%
Colectomy
14%
Disease
13%
Cohort Effect
13%
Prospective Cohort Study
13%
TNF Inhibitor
13%
Follow up
13%
Drug
12%
Quality of Life
11%
Crohn's Disease
11%
Patient with Ulcerative Colitis
10%
Surgery
10%
Ulcerative Colitis
9%
Cytokine
8%
Combination Therapy
8%
Anti-Inflammatory Drug
8%
Age
7%
Macrophage
7%
Proteinase Inhibitor
6%
Pooled Analysis
6%
Older Adult
6%
Primary Sclerosing Cholangitis
6%
Carbohydrate Intake
6%
Granulocyte
6%
Randomized Controlled Trial
6%
Linoleic Acid
6%
Experience
6%
Portal Vein Thrombosis
6%
T-Helper Cell
6%
Health Care Cost
6%
Cystatin C
6%
Polyunsaturated Fatty Acid
6%
Frailty
6%
Biosimilar
6%
Cataract
6%
Infection
6%
Case-Control Study
6%
Patient with Obesity
6%
Bariatric Surgery
6%
Surgery for Inflammatory Bowel Disease
6%
Corticosteroid
6%
Fistula
6%
Anal Fistula
6%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
45%
Crohn's Disease
44%
Cohort Study
35%
Remission
28%
Ulcerative Colitis
20%
Infection
19%
Atorvastatin
18%
Inflammation
18%
Tumor Necrosis Factor
15%
Anti-Inflammatory Drug
15%
Tumor Necrosis Factor Inhibitor
13%
Observational Study
13%
Antiinflammatory Activity
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Calgranulin
7%
Steroids
7%
Adalimumab
7%
Endotoxin
6%
Biological Product
6%
Oxidized Low Density Lipoprotein
6%
Immunosuppressive Agent
6%
Vein Thrombosis
6%
Cataract
6%
Tofacitinib
6%
Intrahepatic Cholestasis
6%
Mercaptopurine
6%
Incidence
6%
Immunology and Microbiology
Monocyte
64%
Inflammatory Bowel Disease
30%
Macrophage
21%
Tumor Necrosis Factor
17%
Inflammation
15%
CD16
14%
Ulcerative Colitis
8%
Crohn's Disease
8%
Immunomodulating Drugs
7%
Inflammatory Disorder
6%
Density
6%
Alpha 1-Antitrypsin
6%
Immunosuppressive Drug
6%
Pulmonary Inflammation
6%
Golimumab
6%
Blood Plasma
6%
Mucosa
6%
Death Receptor
6%
Infectious Disease
6%
Infection
6%
Biological Product
6%
